198 related articles for article (PubMed ID: 23016424)
1. [Research on cationic vector-mediated RNAi].
Zhang X; Ding H; Wang B; Cui S; Zhao Y; Jin W; Zhang S; Jin M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):722-6. PubMed ID: 23016424
[TBL] [Abstract][Full Text] [Related]
2. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
3. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of RNA interference mediated by cationic liposomes].
Han W; Zhen Y; Zhang S; Zhao Y; Sun Y; Guo X; Wang E; Liu Z; Sun Y
Sheng Wu Gong Cheng Xue Bao; 2015 Aug; 31(8):1239-46. PubMed ID: 26762045
[TBL] [Abstract][Full Text] [Related]
5. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.
Dalby B; Cates S; Harris A; Ohki EC; Tilkins ML; Price PJ; Ciccarone VC
Methods; 2004 Jun; 33(2):95-103. PubMed ID: 15121163
[TBL] [Abstract][Full Text] [Related]
6. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
[TBL] [Abstract][Full Text] [Related]
7. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation.
Barichello JM; Ishida T; Kiwada H
Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901
[TBL] [Abstract][Full Text] [Related]
8. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
9. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
10. Effects of cationic lipids in cationic liposomes and disaccharides in the freeze-drying of siRNA lipoplexes on gene silencing in cells by reverse transfection.
Hattori Y; Hu S; Onishi H
J Liposome Res; 2020 Sep; 30(3):235-245. PubMed ID: 31185779
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
13. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; Giovannangeli C; Behr JP; Demeneix BA
J Gene Med; 2005 Feb; 7(2):198-207. PubMed ID: 15515135
[TBL] [Abstract][Full Text] [Related]
14. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
15. Agitation during lipoplex formation harmonizes the interaction of siRNA to cationic liposomes.
Barichello JM; Kizuki S; Tagami T; Soares LA; Ishida T; Kikuchi H; Kiwada H
Int J Pharm; 2012 Jul; 430(1-2):359-65. PubMed ID: 22525078
[TBL] [Abstract][Full Text] [Related]
16. Cell type and transfection reagent-dependent effects on viability, cell content, cell cycle and inflammation of RNAi in human primary mesenchymal cells.
Yang HY; Vonk LA; Licht R; van Boxtel AM; Bekkers JE; Kragten AH; Hein S; Varghese OP; Howard KA; Öner FC; Dhert WJ; Creemers LB
Eur J Pharm Sci; 2014 Mar; 53():35-44. PubMed ID: 24345796
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
[TBL] [Abstract][Full Text] [Related]
18. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
[TBL] [Abstract][Full Text] [Related]
20. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
